drugset / Trial / NCT07253233

Treatment of Spinal Cord Injury Using Autologous Concentrated Growth Factors

NCT07253233 ↗

Phase 0 Not yet recruiting 10 enrolled Third Affiliated Hospital, Sun Yat-Sen University
NaSingle-groupOpen-labelTreatment

Summary

Spinal cord injury (SCI) is a severe disorder of the central nervous system, and effective clinical management remains a significant global challenge. Current therapeutic approaches can only partially restore neurological function, leaving the majority of individuals with SCI facing profound and lifelong disabilities. The Department of Spine Surgery at the Third Affiliated Hospital of Sun Yat-sen University is conducting a clinical study on the use of autologous concentrated growth factors for the treatment of spinal cord injury, with the aim of developing a novel and effective clinical intervention strategy.

Timeline

Start
2025-12-01
Primary completion
2027-07-31
Completion
2027-07-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Concentrated Growth Factors Unknown — Other

Indications